It was shown that survivin was present in EVs secreted by prostate cancer cells and survivin levels in plasma-derived EVs from newly diagnosed prostate cancer patients (both early-stage and advanced cancers) and patients who relapsed after chemotherapy were significantly increased. This evidence concerns the gene BIRC5 and cancer.